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DNA methyltransferase3A as
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Here, we explore whether silencing via promoter DNA
methylation plays a role in neural versus neural crest cell
lineage decisions. We show that DNAmethyltransferase3A
(DNMT3A) promotes neural crest specification by di-
rectly mediating repression of neural genes like Sox2 and
Sox3. DNMT3A is expressed in the neural plate border,
and its knockdown causes ectopic Sox2 and Sox3 ex-
pression at the expense of neural crest markers. In vivo
chromatin immunoprecipitation of neural folds dem-
onstrates that DNMT3A specifically associates with CpG
islands in the Sox2 and Sox3 promoter regions, resulting
in their repression by methylation. Thus, DNMT3A
functions as a molecular switch, repressing neural to favor
neural crest cell fate.
Supplemental material is available for this article.
Received June 17, 2012; revised version accepted September
13, 2012.
During development, neural crest stem cells contribute
to many uniquely vertebrate derivatives, including pe-
ripheral ganglia and the craniofacial skeleton (Le Douarin
1982). Although neural crest precursors initially reside
within the neural tube, they subsequently segregate from
other neuroepithelial cells by a heretofore unknownmech-
anism. Whereas the remainder of the neural tube will
form the CNS, neural crest cells undergo an epithelial-
to-mesenchymal transition (EMT), emigrate from the
CNS, and migrate into the periphery (Sauka-Spengler
and Bronner-Fraser 2008). Single-cell lineage analysis
has shown that individual cells within the dorsal neural
tube can contribute to both the CNS and neural crest
(Bronner-Fraser and Fraser 1988), suggesting that premigra-
tory dorsal neural tube cells are not yet committed to
a neural crest fate. Subsequently, a subpopulation of dorsal
neural tube cells produces bona fide neural crest cells that
migrate extensively to populate diverse derivatives, rang-
ing from peripheral neurons to craniofacial cartilage and
melanocytes. The molecular mechanisms underlying the
neural tube-to-neural crest transition are a long-standing
mystery. In this study, we explored the possibility that
silencing via promoter DNA methylation plays a role in
this cell fate choice during embryonic development.
De novo DNA methyltransferases (DNMTs) recognize
CpG islands and newly methylate DNA by catalyzing
the transfer of a methyl group to cytosine residues (Cheng
and Blumenthal 2008). In cancer and stem cells, when
such CpG island methylation occurs in the promoter re-
gion, gene expression is inhibited (Momparler and Bovenzi
2000; Miranda and Jones 2007; Altun et al. 2010). The de
novo DNMTs DNMT3A (Jurkowska et al. 2011) and
DNMT3B are vital for normal mammalian development
and have been implicated in disease (Linhart et al. 2007;
Ehrlich et al. 2008; Yan et al. 2011). For example,
DNMT3A/ mice die several weeks after birth, and
DNMT3B/ embryos have rostral neural tube defects
and growth impairment (Okano et al. 1999). Moreover,
mutations in human DNMT3B result in immunodefi-
ciency centromeric instability facial anomalies syndrome,
in which patients exhibit craniofacial abnormalities (Jin
et al. 2008), suggesting a defect in neural crest develop-
ment. In contrast, the function of DNMT3A in early
development is not understood. Here, we show that
DNMT3A plays a critical function in de novo methyl-
ation during early nervous system and neural crest
development.
Results and Discussion
Expression pattern of DNMT3A in the early
chick embryo
As a first step in analyzing its possible function, we
examined the expression pattern of DNMT3A transcripts
by in situ hybridization. Intriguingly, DNMT3A is highly
expressed at the neural plate border at gastrula stages,
contrasting with low levels in the neural plate (Fig. 1A, St.
5–7). Subsequently, transcripts are confined to the neural
folds containing premigratory neural crest precursors
(Fig. 1A, St. 9) and, later, in migrating neural crest cells,
labeled with HNK-1 antibody (Supplemental Fig. S1A).
Thus, at early developmental stages, DNMT3A is selec-
tively expressed in tissues associated with neural crest
and early neural tube development.
Knockdown of DNMT3A blocks neural crest
specification, as assayed by FoxD3 expression,
in a cell-autonomous manner
To test the functional consequences of loss of DNMT3A
during neural crest specification, we designed two dif-
ferent fluorescein-tagged translation-blocking antisense
morpholino oligonucleotides (MOs) targeted against
DNMT3A. These were electroporated into one-half of
the early chick embryo at gastrulation stages 4/5, with the
uninjected side serving as an internal control (Basch et al.
2006). To verify that the knockdown was effective, we
performed Western blots comparing the protein levels in
the electroporated side versus the control half of the same
embryo and found that a band corresponding to DNMT3A
protein was significantly decreased in the presence of
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DNMT3AMOs (Fig. 1B).We examined the effects of loss of
DNMT3A on expression of FoxD3, as it is one of the
earliest neural crest markers to appear in the dorsal neural
tube. FoxD3 was dramatically down-regulated after loss of
DNMT3A on the morpholino-electroporated side of the
embryo (Fig. 1C,D) in an apparently dose-dependent fash-
ion, as the severity of the phenotype increased with the
amount of morpholino introduced (Supplemental Fig. S1B).
To control for the specificity of action of the DNMT3A
morpholino and demonstrate that the observed pheno-
type was not due to off-target binding, we coelectroporated
the DNMT3A MO with a construct encoding exogenous
DNMT3A under the control of a cranial FoxD3 enhancer,
NC1, which turns on at early stage 8. This enhancer drives
exogenous DNMT3A only in premigratory cranial neural
crest cells. Despite the fact that the morpholino was
introduced much earlier, this resulted in marked rescue
of the loss-of-function phenotype, restoring FoxD3 expres-
sion (Fig. 2A,B). To examine whether the catalytic activity
of DNMT3A was important for its function, we coelec-
troporated the DNMT3A morpholino and a rescue con-
struct in which the catalytic domains of DNMT3A were
removed. Under coelectroporation conditions identical to
those above, this mutated form of DNMT3A failed to
rescue the loss-of-function phenotype (Supplemental Fig.
S2A,B). This demonstrates that catalytic activity is critical
for DNMT3A function during neural crest development.
Although we hypothesize that DNMT3A acts in a cell-
autonomous fashion in the presumptive neural crest
cells, it is possible that aberrant interactions
between neural crest precursors and more ventral
neural tube cells result in a neural crest pheno-
type. DNMT3A is expressed at high levels at the
neural plate border, neural folds, and premigra-
tory neural crest but is also expressed in the
neural tube, albeit at much lower levels. To test
whether the function of DNMT3A is cell-auton-
omous, we compared its effect on the neural crest
versus the rest of the neural tube. Because we
cannot selectively target the neural crest region
in a predictable fashion, we electroporated the
morpholino into the entire neural tube on one
side of each embryo and into the neural tube with
the exception of the dorsal neural fold region on
the opposite side. In 100% of cases, we noted
that down-regulation of FoxD3 only occurred
when DNTM3A protein was down-regulated in
the presumptive neural crest itself (Fig. 2C). The
finding that FoxD3 is absent from cells contain-
ing the DNMT3A MO but present in cells lack-
ing the DNMT3A MO in the dorsal neural fold
region definitively demonstrates that DNMT3A
acts cell-autonomously (Supplemental Fig. S2D).
Multiplex analysis reveals that loss
of DNMT3A up-regulates neural genes while
down-regulating neural crest specifier genes
In order to understand global and multiplexed
changes in gene expression caused by DNMT3A
knockdown, we performed NanoString analysis
to monitor and quantify 73 transcripts, including
genes expressed in the neural crest, neural tube,
neural plate, neural plate border, placodes, and
nonneural ectoderm and those involved in cell
proliferation and cell death. EachDNMT3Aknock-
down embryo was analyzed at late stage 8, by comparing
the morpholino-electroporated side with the uninjected
side of the same embryo. Because DNMTs are thought to
inhibit transcription bymethylating the promoter region of
target genes, we were particularly interested in genes that
were up-regulated as a consequence of down-regulating
DNMT3A, as these represent potential direct targets.
Interestingly, the results show that transcriptional regula-
tors characteristic of neural fate specification—Sox2 and
Sox3 as well as the neural plate border gene Zic1 and some
EMT and placode-related genes—were up-regulated after
DNMT3A knockdown (Fig. 3A; Supplemental Fig. S3A–C).
Sox2 (Pevny and Lovell-Badge 1997; Graham et al.
2003) was of particular interest, since its misexpression
in the neural folds blocks expression of the neural crest
gene Snail2 (Wakamatsu et al. 2004). Furthermore, Sox2
is a well-known pluripotency gene and is one of the four
genes necessary to reprogram somatic cells into pluripo-
tent stem cells (Pawlak and Jaenisch 2011). Therefore, we
used in situ hybridization to verify the up-regulation of
Sox2 noted byNanoString analysis. The results show that
loss of DNMT3A causes expansion of Sox2 into the
neural crest territory, whereas on the control side of the
same embryo, Sox2 is absent from the neural crest do-
main (Fig. 3B). Interestingly, this is accompanied by
changes in morphology of the dorsal neural tube, which
appears less broad and more neuroepithelial than the
control side. In contrast to Sox2, the pluripotency genes
Nanog and Oct4/PouV exhibited little or no expression
Figure 1. DNMT3A is expressed at sites of neural crest formation, and its loss of
function blocks expression of the neural crest specifier gene FoxD3. (A)
Expression pattern of DNMT3A in stage 5–9 chick embryo by in situ hybridiza-
tion.DNMT3A is strongly expressed in the neural plate border (St. 5–7) and dorsal
neural tube (St. 9). Bars: whole mount, 500 mm; section, 100 mm. (B) Western blot
of dorsal neural tubes (five pooled embryos) shows that DNMT3A protein level
was reduced on the electroporated side compared with the control side; a-tubulin
levels were unchanged. (C) Two morpholinos against DNMT3A (MO1 and MO2;
FITC in inset) caused reduction of FoxD3 expression at stage 8 after electro-
poration (shown at left; arrow) compared with the contralateral internal control
side or control morpholino-electroporated embryos. Bar, 200 mm. (D) Quantita-
tion of numbers of DNMT3A MO-treated and control MO-treated embryos with
either strong or mild loss of FoxD3 expression of MO versus the control side
of same embryo. The asterisk indicates significant differences (P < 0.01) by
contingency table followed by x2 test. See also Supplemental Figure S1.
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in the cranial neural tube (Canon et al. 2006; N Hu and
ME Bronner, unpubl.). Moreover, their expression was
unchanged after DNMT3A knockdown (data not shown).
Sox2 and Sox3 are paralogs with overlapping function.
Therefore, we examined the effects of DNMT3A knock-
down on Sox3 expression and found that, like Sox2, it is
up-regulated in the dorsal neural tube after morpholino
knockdown (Fig. 3B). Thus, both genes are affected simi-
larly, although Sox2 comes on earlier than Sox3 and
appears to be the dominant neural specifier. Like Sox2
and Sox3, Zic1 also was up-regulated in the dorsal neural
tube after loss of DNMT3A (Fig. 3B).
Concomitant with up-regulation of Sox2, neural crest
specification markers were down-regulated in DNMT3A
knockdown embryos, as shown in our NanoString data
(Fig. 3A). This was verified by in situ hybridization for
other neural crest specifiers and dorsal neural tube genes,
including Sox9, Sox10, Snail2, Ets1, Wnt1, and N-Myc.
Like FoxD3, all of these appeared to be down-regulated
upon loss of DNMT3A (Fig. 4). Given that Wnt signaling
has been implicated in neural crest specification
and Wnt1 was down-regulated after DNMT3A
knockdown, we tested whether activated b-catenin
could rescue theDNMT3Amorpholino phenotype.
However, the results show no change in FoxD3
expression (Supplemental Fig. S4A,B).
Coimmunostaining of Sox2 and FoxD3 in a sin-
gle embryo treatedwith theDNMT3AMO further
demonstrates that loss of DNMT3A up-regulates
neural genes such as Sox2 while down-regulating
neural crest specifier genes such as FoxD3 (Fig. 3C;
Supplemental Fig. S3E). We noted no significant
change in cell death, as shown by Casp-3 staining
(Supplemental Fig. S4C). In addition, there was no
change in the expression of neural plate border
genes like Msx1 and BMP4 in the dorsal neural
tube (Supplemental Fig. S4D).
To demonstrate a direct link between Sox2 up-
regulation and the reduction of neural crest gene
expression, we electroporated a construct con-
taining avian Sox2 (Wakamatsu et al. 2004) into
the stage 4–5 neural plate, resulting in overex-
pression throughout the neural tube, including
ectopic expression in the dorsal region. Consis-
tent with our findings after DNMT3A knock-
down, this caused down-regulation of the neural
crest specifier genes FoxD3, Sox10, and Snail2
(Supplemental Fig. S5). For the reciprocal experi-
ment, we examined whether morpholino knock-
down of Sox2 and/or Sox3 was sufficient to in-
duce neural crest cell fate in the neural tube. Loss
of Sox2, Sox3, or both in combination failed to
convert neural tube to neural crest cells. How-
ever, these factors are critical for normal neural
induction, and their loss, as expected, led to severe
neural defects.
Neural specifier genes Sox2 and Sox3 are direct
targets of DNMT3A
The NanoString and in situ data raise the in-
triguing possibility that de novo methylation of
the Sox2 promoter region by DNMT3A may be
essential for repression of the Sox2 in the dorsal
neural folds and necessary for the switch in its
identity from neural to neural crest. To test this in
the in vivo context, we used chromatin immunoprecip-
itation (ChIP) followed by quantitative PCR (qPCR) to
assess whether Sox2 is a direct target of DNMT3A. To
this end, dorsal neural folds were dissected from stage 8
embryos and processed for microChIP as previously de-
scribed (Betancur et al. 2010; Strobl-Mazzulla et al. 2010).
The data show that DNMT3A associates with the Sox2
promoter region but not with the N2 enhancer region of
Sox2 (Fig. 5; Uchikawa et al. 2003). Similar to Sox2, ChIP
analysis shows that DNMT3A also occupies the promoter
region of Sox3, the paralog of Sox2 (Fig. 5). In contrast,
Zic1, which was also up-regulated after DNMT3A knock-
down, does not appear to be a direct target of DNMT3A,
since ChIP analysis failed to show binding at its promoter
region (data not shown).
We further examined the methylation pattern of Sox2
and Sox3 in the dorsal neural tube at stage 8. As expected,
the results show that both Sox2 and Sox3 are methylated
in the vicinity of their promoters (Supplemental Fig.
S2C). Taken together, these findings definitively show
Figure 2. Loss of FoxD3 is rescued by exogenous DNMT3A in a neural crest
cell-autonomous manner. (A) Expression of DNMT3A protein in premigratory
neural crest rescues the loss of the FoxD3 phenotype: Each embryo was electro-
porated on the left side with either the DNMT3A MO or control MO (green in
inset) in combination with either a DNMT3A rescue construct (NC1-DNMT3A)
or empty vector (NC1 alone). The rescue construct contains the coding region of
DNMT3A under the control of a cranial neural crest-specific enhancer for FoxD3
plus HSV-tk basal promoter. At stage 10, the loss of neural crest marker FoxD3
was largely rescued by NC1-DNMT3A plus the DNMT3A MO. Overexpression
of the DNMT3A rescue construct alone did not alter FoxD3 expression. Bar, 500
mm. (B) Quantitation of the percentage of DNMT3A knockdown (K.D.), rescue
(RES), and overexpression (Over) embryos in A with either strong or mild loss of
FoxD3 expression. P < 0.01 by contingency table followed by x2 test. Knockdown, n
= 10; rescue, n = 13; overexpression, n = 5. (C) Effect of DNMT3A loss of function is
cell-autonomous to the neural crest-forming region: The DNMT3AMO or control
MO was electroporated throughout the neural tube on the left side and into the
neural tube with the exception of the dorsal neural folds (circled) on the right side.
Loss of FoxD3 only occurred when the dorsal neural fold was electroporated with
the DNMT3A MO, as evident in the transverse section. DNMT3A MO, n = 8/8;
control MO n = 12/12. P < 0.01 by contingency table followed by x2 test. Bar, 100
mm. See also Supplemental Figure S2.
Hu et al.
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that DNMT3A directly binds to the promoter regions of
Sox genes and represses their transcription via methyla-
tion, thus allowing the acquisition of neural crest gene
expression.
Our data show that DNA methylation act as a molec-
ular switch to turn off neural tube transcription factors,
thus facilitating neural crest gene expression and fate
acquisition. Previous studies on the molecular mecha-
nisms of DNMT3A function have been focused on
hematopoietic and neural stem cells and glioma cells in
tissue culture. These studies using in vitro data show that
DNMT3A can promote cell differentiation by repressing
pluripotency genes (Trowbridge and Orkin 2011). Consis-
tent with this, our results in the developing embryo
demonstrate that DNMT3A promotes neural crest cell
type specification in an in vivo context by repressing
neural genes like Sox2 and Sox3. Although the mecha-
nism by which DNMT3A is recruited to the promoter
region of target genes is unknown, it has been shown to
interact with numerous factors on transcription factor
arrays (Hervouet et al. 2009). Although these have yet to
be validated, particularly in vivo, this list includes some
neural plate border and neural crest specifier genes like
Msx1, tfAP2a, Id2, and Myc. Thus, it is intriguing to
speculate that DNMT3A may be recruited to the Sox2
promoter by some of these factors that are selectively
expressed in the neural crest-forming domain.
In some cases, de novo methyltransferases can also
mediate methylation-independent gene repression by
colocalizing with heterochromatin and associating with
HP1 and MeCBP (methyl-CpG-binding protein). For ex-
ample, in zebrafish neurogenesis, DNMT3B cooperates
with histone methyltransferase G9a to inhibit expression
of Lef1 (Rai et al. 2010). Thus, it is particularly interesting
that, in the neural folds, DNMT3A acts via regulation of
the promoter region rather than the enhancer region, as
demonstrated by our ChIP data. This shows that, in ad-
dition to cis-regulatory events, epigenetic influences are
a critical mechanism for regulating transcription. Our
discovery that DNA methylation promotes neural crest
specification at the expense of neural tube identity pro-
vides important insights into the mechanisms that
determine whether a cell becomes part of the CNS or
peripheral nervous system.
Materials and methods
Embryos
Fertilized chicken eggs were incubated at 37°C to the desired stages.
In situ hybridization
Embryos were fixed with 4% paraformaldehyde, washed with PBS/0.1%
Tween, dehydrated in MeOH, and stored at 20°C. Whole-mount in situ
hybridization was performed as described (Wilkinson 1992; Acloque et al.
2008). Dioxigenin-labeled RNA probes were made from DNA plasmids or
Figure 3. Sox2, Sox3, and Zic1 are potential downstream targets of
DNMT3A, as identified using multiplex NanoString analysis and
verified by in situ hybridization. (A) NanoString analysis reveals
genes up-regulated (above diagonal lines) and down-regulated (below
diagonal lines) by DNMT3A knockdown. The injected side of
DNMT3AMO-treated embryos shows >25% up-regulation of neural
tube genes Sox2, Sox3, and Zic1 (n = 3), and there was >25%
reduction of neural crest specifier genes Snail2, Sox9, TNIP1, FoxD3,
Sox8, and Sox10 (see also Supplemental Fig. S3). No differences were
noted in control morpholino-treated embryos (n = 3) (Supplemental
Fig. S3). The blue line represents 25% variation between the
injected and uninjected sides. (B) Transverse sections of stage 8
embryos electroporated with the DNMT3A MO (FITC; inset)
confirm that Sox2, Sox3, and Zic1 expression was expanded into
the neural crest territory (blue circle) when compared with the
internal control side (n = 12 of 12). Bars: whole mount, 200 mm;
section, 100 mm. (C) Transverse section of stage 8 embryos electro-
porated with the DNMT3A MO (green) confirms that Sox2 (red)
protein expression was expanded into the neural crest territory (red
circle) when compared with the internal control side, while FoxD3
(blue) protein expression was missing in the neural crest territory
(blue circle). n = 7 of 8. Control morpholino-treated embryos show
equivalent Sox2 and FoxD3 expression on both sides (Supplemental
Fig. S3). Bar, 100 mm.
Figure 4. Neural crest specifier and dorsal neural tube genes are
down-regulated after knockdown of DNMT3A. The DNMT3A MO
or control MO was electroporated into the left side of the embryo
(FITC, shown in insets), and the subsequent effects on expression
patterns of neural crest and dorsal neural tube genes were exam-
ined by whole-mount in situ hybridization. Sox9, Sox10, Ets1,
Snail2, N-myc, and Wnt1 are down-regulated (arrow) upon in-
troduction of the DNMT3A MO when compared with the internal
control side or control morpholino-electroporated embryos. Bar,
200 mm.
DNMT3A in neural crest specification
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ESTs of DNMT3A, Sox2, Sox9, Sox10, Snail2, FoxD3, Wnt1, Ets1, Nmyc,
Msx1, and Bmp4. Embryos were sectioned at 16–18 mm.
Electroporation
Embryos were electroporated at stage 4–5 as described (Sauka-Spengler and
Barembaum 2008) using DNMT3AMO1 (over ATG codon) (TGGGTGTG
TCACTGCTTTCCACCAT) and/or DNMT3AMO2 (95 nucleotides up-
stream of ATG) (CAGTGTCCCCACGGCGCTTCCTGCT). The rescue
construct included the coding region of DNMT3A (NM001024832.1) under
the control ofNC1 or emptyNC1 as control. For each embryo, 0.6mMMO +
0.5 mg/mL DNAwas used for knockdown experiments, and 0.4 mM MO +
1.5 mg/mL DNA was used for rescue experiments. The MO was targeted to
the presumptive neural crest region with five 50-msec pulses of 5.2 V at
100-msec intervals. Electroporated embryos were maintained in culture
dishes with 1 mL of albumen and then fixed.
NanoString nCounter
Half-dorsal neural folds of DNMT3AMO-treated embryos were dissected
in lysis buffer (Ambion RNAqueous-Micro Isolation kit). RNA lysates
were hybridized to the probe set, incubated overnight at 65°C, washed,
eluted according to the nCounter Prep Station manual, and counted by
nCounter Digital Analyzer.
ChIP
Dorsal neural tubes from 25 stage eight embryos were dissected and
extracted (three experiments per condition). Cells were cross-linked and
sonicated to yield 300- to 800-base-pair fragments. Samples were evenly
split for DNMT3A antibody (Abcam), control rabbit anti-IgG (Abcam),
and Input. Antibodies were preincubated with Protein A magnetic beads
(Invitrogen) before incubation with a sonicated protein–DNA complex.
Samples were washed, eluted, and reverse cross-linked. Final DNA pull-
downwas purified and served as a template for qPCR of the Sox2 promoter
region. Three replicates were loaded for each sample, and the results were
quantified using the DDCt method. Analysis was done using Applied
Biosystems’ instructions.
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